TAG:
pathology service
Pathologists Not Enrolled In PECOS By July 6 Risk Denial of Medicare Claims
By Robert Michel | From the Volume XVII No. 9 – June 21, 2010 Issue
JULY 6, 2010, IS THE NEW DEADLINE for pathologists to enroll in the Provider Enrollment, Chain and Ownership System (PECOS) or risk being denied payment for Medicare claims. The federal Centers for Medicare & Medicaid Services (CMS) recently issued a statement that it will not p…
EMR Donations, Client Bill Issues in Anatomic Path
By Robert Michel | From the Volume XVII No. 7 – May 10, 2010 Issue
CEO SUMMARY: In today’s market for anatomic pathology services, local pathology practices are facing tough competition from national pathology companies that are quite aggressive at using EHR donations and discounted client bill arrangements to win new clients. Attorney Jane Pi…
Irish Labs Are at an Important Crossroads
By R. Lewis Dark | From the Volume XVII No. 7 – May 10, 2010 Issue
GLOBAL OUTSOURCING OF CLINICAL LABORATORY TESTING IN IRELAND has entered its second phase. The Irish Health Service Executive (HSE) granted Quest Diagnostics Incorporated a contract for an additional two-years of cervical cancer screening tests while…
Errors in Surgical Pathology Surface in the United Kingdom
By Robert Michel | From the Volume XVII No. 6 – April 19, 2010 Issue
ERRORS IN SURGICAL PATHOLOGY DIAGNOSES made the newspapers in the United Kingdom earlier this month. The accuracy of histopathology results at the Bristol Royal Infirmary (BRI) in Bristol, England was the subject of a news story in The Sunday Telegraph on April 10. Under the headlin…
Use of Point-of-Care Testing Reduces Mortality by 50%
By Robert Michel | From the Volume XVII No. 5 – March 29, 2010 Issue
CEO Summary: In a thinly-populated region the size of Texas and New Mexico combined, an integrated clinical care program based on point-of- care testing (POCT) has delivered impressive gains in health outcomes. For rural residents, mortality rates from cardiovascular disease have fallen b…
Baylor Pathologists Form Lab with US Oncology
By Robert Michel | From the Volume XVII No. 4 – March 8, 2010 Issue
CEO SUMMARY: In Dallas, Pathologists Bio-Medical Laboratories is part of a new laboratory partnership that includes Baylor Health Care System, Texas Oncology, and US Oncology. The four partners ponied up a total of $40 million in cash and debt to build a state-of-the art laboratory in a 1…
Preparing for New Lab Role In Personalized Medicine
By Robert Michel | From the Volume XVII No. 4 – March 8, 2010 Issue
CEO SUMMARY: Laboratory medicine is about to find itself between the two jaws of a powerful vise. One jaw is pending major legislative overhaul of the entire healthcare system, along with dwindling reimbursement as Medicare and Medicaid runs out of money. The other jaw is personalized med…
Pathology Errors in Canada Make National News Once Again
By Robert Michel | From the Volume XVII No. 4 – March 8, 2010 Issue
YET ONE MORE TIME, pathology errors are making national headlines in Canada. News of errors by a surgeon and a pathologist in a Windsor, Ontario, hospital caught provincial health officials off balance. The simple story is that an experienced surgeon at 305-bed Hotel-Dieu Grace Hospital …
Pace of Lab Acquisitions Increased during 2009
By Robert Michel | From the Volume XVII No. 3 – February 15, 2010 Issue
CEO SUMMARY: After two years of relatively slow sales of clinical labs, there is pent up demand for lab acquisitions and a declining supply of independent labs available for sale. That’s the assessment of one expert on laboratory mergers and acquisitions, who predicts that the accelerat…
Ireland Is Restructuring National Lab Test System
By Robert Michel | From the Volume XVII No. 2 – January 25, 2010 Issue
CEO SUMMARY: Working from a consultant’s report and recommendations based on studies dating back to 2006 and 2007, Ireland’s Health Service Executive is moving forward to effect a comprehensive reconfiguration of clinical laboratory testing across the nation. This ma…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized